PHBI Pharmagreen Biotech Inc.

Fundamentals / CIK 0001435181 / USD

Pharmagreen Biotech Inc. reported $140K in total assets and a net loss of $501K through September 30, 2022 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PHBI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2018 to 2022), reported in USD.

$0$0$0-$4.24MFY 2018 Net Income: -$1.07M2018FY 2019 Net Income: -$768K2019FY 2020 Net Income: -$2.48M2020FY 2021 Net Income: -$4.53M2021FY 2022 Net Income: -$876K2022

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Research & Development -- -- -- $4.0K $7.6K
Total Operating Expenses $1.10M $744K $486K $642K $749K
Operating Income -$1.10M -$744K -$486K -$642K -$749K
Interest Expense $29K $681K $299K $3.8K --
Income Before Tax -- -- -$2.48M -$769K --
Income Tax Expense $0 $0 $0 -- --
Net Income -$876K -$4.53M -$2.48M -$768K -$1.07M
Basic EPS -- -$0.02 -$0.03 -$0.01 -$0.04
Diluted EPS -- -$0.02 -$0.03 -$0.01 -$0.04
Basic Shares Outstanding 403.7M 293.7M 82.1M 74.1M 24.8M
Diluted Shares Outstanding 218.7M 326.0M 388.4M 364.9M 293.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Revenue $597 $963 -- -- $0 $0 -- --
Cost of Revenue $389 $985 -- -- $0 $0 -- --
Gross Profit $208 -$22 -- -- $0 $0 -- --
Total Operating Expenses $82K $120K $181K $198K $241K $459K $204K $273K
Operating Income -$82K -$188K -$181K -$198K -$241K -$1.04M -$204K -$273K
Interest Expense $8.2K $8.1K $8.3K -$2.1K $11K $10K $10K $7.6K
Net Income -$163K -$188K -$39K -$110K $252K -$1.04M $19K -$831K
Basic EPS -- -- -- -- $0.00 -- $0.00 --
Diluted EPS -- -- -- -- $0.00 -- $0.00 --
Basic Shares Outstanding -- -- -- -- 406.6M 394.4M 384.2M --
Diluted Shares Outstanding -- -- -- -- 613.5M -- -- --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Cash & Cash Equivalents $8.0K $25K $12K $63K $152K
Cash & Short-Term Investments $8.0K $25K $12K $63K $152K
Accounts Receivable, Net $383 $290 -- -- --
Inventory $0 -- -- -- --
Total Current Assets $209K -- $266K $189K $198K
Property, Plant & Equipment, Net -- -- -- $441K $251K
Total Non-Current Assets $0 -- $0 $441K $251K
Total Assets $209K $373K $266K $630K $449K
Accounts Payable $645K $580K $455K $830K $590K
Total Current Liabilities $1.91M $2.03M $3.17M $1.46M $1.84M
Long-Term Debt -- -- $30K -- --
Total Non-Current Liabilities $119K $39K $33K $1.6K $693
Total Liabilities $2.03M $2.07M $3.20M $1.46M $1.84M
Total Debt (incl. Leases) -- -- $30K -- --
Common Stock $442K $381K $96K $76K $72K
Retained Earnings -$12.57M -$11.70M -$7.17M -$4.73M -$3.96M
Accumulated Other Comp. Income $94K -$8.4K $37K $48K $39K
Total Stockholders' Equity -$1.78M -$1.69M -$2.93M -$834K -$1.39M
Total Equity -$1.82M -$1.69M -$2.93M -$834K -$834K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Cash & Cash Equivalents $5.3K $7.4K $25K $8.0K $24K $3.0K $10K $25K
Cash & Short-Term Investments $5.3K $7.4K $25K $8.0K $24K $3.0K $10K $25K
Accounts Receivable, Net $606 $569 $465 $383 $316 $70 -- $290
Inventory $9.2K $9.5K -- $0 -- -- -- --
Total Current Assets $51K $74K -- $209K -- -- -- --
Total Non-Current Assets $89K $89K -- $0 -- -- -- --
Total Assets $140K $163K $212K $209K $191K $198K $358K $373K
Accounts Payable $697K $691K $685K $645K $622K $623K $611K $580K
Total Current Liabilities $2.17M $2.06M $1.92M $1.91M $1.99M $2.56M $1.90M $2.03M
Total Non-Current Liabilities $120K $91K $91K $119K $138K $44K $41K $39K
Total Liabilities $2.29M $2.15M $2.01M $2.03M $2.13M $2.60M $1.94M $2.07M
Common Stock $464K $455K $455K $442K $424K $397K $385K $381K
Retained Earnings -$12.97M -$12.80M -$12.61M -$12.57M -$12.46M -$12.72M -$11.68M -$11.70M
Accumulated Other Comp. Income $48K $79K $82K $94K $13K -$28K -$11K -$8.4K
Total Stockholders' Equity -$2.10M -$1.94M -$1.75M -$1.78M -$1.89M -$2.40M -$1.58M -$1.69M
Total Equity -$2.15M -$1.99M -$1.80M -$1.82M -$1.94M -$2.40M -$1.58M -$1.69M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Net Income -$876K -$4.53M -$2.48M -$769K -$1.07M
Change in Receivables -$93 $5 -- -- --
Change in Payables -- -- $293K -- --
Operating Cash Flow -$427K -$206K -$608K -$318K -$786K
Capital Expenditure -- -- -- -$196K -$251K
Free Cash Flow -- -- -- -$514K -$1.04M
Investing Cash Flow -- -- -- -$196K -$251K
Common Stock Issued -- -- $570K $75K $298K
Financing Cash Flow $314K $257K $563K $433K $1.12M
Net Change in Cash -$17K $13K -$50K -$89K $135K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Net Income -$163K -$267K $39K -$110K $252K -$998K -$19K -$831K
Change in Receivables $409 -$104 -$82 -$119 -$194 -$8 $228 --
Operating Cash Flow $7.5K -$34K -$19K -$92K -$130K -$56K -$149K -$55K
Common Stock Issued $0 $0 $0 -- -$6.5K $26K $92K --
Financing Cash Flow $18K $19K $47K $0 $113K $65K $136K $37K
Net Change in Cash -$2.1K -$18K $17K -$16K $21K -$7.4K -$15K --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Return on Assets (ROA) -419.0% -1214.8% -932.5% -121.8% -238.9%
Current Ratio 0.11x -- 0.08x 0.13x 0.11x
Quick Ratio 0.11x 0.01x 0.00x 0.04x 0.08x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Return on Assets (ROA) -356.9% -52.7% -441.1% -419.0% -835.1% -1003.4% -1145.0% -1214.8%
Current Ratio 0.02x 0.04x -- 0.11x -- -- -- --
Quick Ratio 0.02x 0.03x 0.01x 0.11x 0.01x 0.00x 0.01x 0.01x
Net Income Growth (YoY) -164.7% -- -310.3% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001435181) · from June 30, 2018 Data through June 30, 2023 · synced Nov 21, 2026, 05:16 UTC · Open in terminal